The present disclosure relates to a communication connection method for a continuous glucose monitoring system. A communication connection method for a continuous glucose monitoring system according to an embodiment of the present disclosure may comprise: a step in which, in order to connect communication between a communication terminal and a sensor transmitter attached to a human body so as to continuously monitor biometric information of the human body, the communication terminal receives information of the sensor transmitter from the sensor transmitter; a step of determining, on the basis of the received information, whether the sensor transmitter is a new sensor transmitter or an already used sensor transmitter; and a step in which, when the sensor transmitter is an already used transmitter, communication connection is controlled on the basis of use information of the already used sensor transmitter. The present disclosure is advantageous in that, if communication between a sensor transmitter inserted into a human body and a communication terminal for receiving glucose data from the sensor transmitter is disconnected, the communication between the existing sensor transmitter and the communication terminal can be quickly connected when the communication is reconnected.

An inhaler device for pulmonary delivery of at least one substance from a drug dose cartridge to an inhaling user, including: a first conduit for conducting a carrier airflow to a proximal opening of a mouthpiece for use by the user; a holder configured to position the dose cartridge within the carrier airflow; and a second conduit for conducting a shunting airflow to the mouthpiece without passing through the dose cartridge position. In some embodiments, a controller connected to a valve controls a rate of carrier airflow, for example by controlling the shunting airflow, based on a sensor indication of airflow rate and a target airflow profile.

A vaporization device includes a first portion and a second portion. The first portion includes a first body defining a first interior volume, a first half of a split-pod, a second half of a split-pod, an opening, a first heating apparatus, and a second heating apparatus. The first half of the split-pod is configured to hold a nicotine-containing liquid. The second half of the split-pod is configured to hold a non-nicotine-containing liquid. The opening separates the first half from the second half of the split-pod. The first heating apparatus is dedicated to the first half. The second heating apparatus is dedicated to the second half. The second portion includes a second body defining a second interior volume and a computing system. The computing system is disposed within the second interior volume. The computing system is configured to vary an amount of current supplied to the first and second heating apparatuses.

A controller for an implantable blood pump, having processing circuitry configured to control an operating speed of an impeller of the implantable blood pump. The processing circuitry being further configured to control activation and deactivation of a sleep mode. During the sleep mode the processing circuitry being configured to measure a level of suction by detecting suction during a predetermined time interval, recording the time at which suction occurred during the predetermined time interval, and generating a graph demonstrating the measured level of suction. The measured level of suction being a percentage of time the implantable blood pump experienced suction during the predetermined time interval. The processing circuitry being configured to reduce the operating speed of the impeller if the measured level of suction exceeds a predetermined threshold.

A spirometry system operable to measure airflow through an air passage defined by a mouthpiece including one or more contact sensors configured to generate at least one mouth contact signal indicative of user mouth contact with the proximal portion of the mouthpiece. The spirometry system can further include an airflow sensor configured to generate an airflow signal corresponding to airflow within the air passage, and processor circuitry communicatively coupled to the one or more contact sensors and to the airflow sensor. The processor circuitry can be configured to determine an indication of an amount of user mouth contact for use with a measurement of airflow by the processor circuitry.

A wearable device comprises first and second transmitting loops coupled with the wearable device. The first and second transmitting loops being further coupled with a data processing unit. Additionally, the second transmitting loop may be coupled with a sensor outputting a measuring signal. The first and second transmitting loops have a property with a readable value dependent on an aging of the object of a wearable device. In addition, the data processing unit is configured to measure the value of the property of the first and second transmitting loops and determine the effects or amount of aging.

Methods, systems, and devices for improving continuous glucose monitoring (“CGM”) are described herein. More particularly, the methods, systems, and devices describe retrieving a machine learning model that is trained to classify CGM sensor data and blanking the CGM sensor data based on an outlier classification from the machine learning model. The system may terminate sensors for which there is an aggregation of blanked CGM sensor data. The methods, systems, and devices described herein may additionally comprise a machine learning model that is trained to detect and correct for erroneous sensor use conditions based on error patterns in sensor data. The system may determine resolutions for correcting the detected erroneous sensor use conditions.

A wearable device comprises first and second transmitting loops coupled with the wearable device. The first and second transmitting loops being further coupled with a data processing unit. Additionally, the second transmitting loop may be coupled with a sensor outputting a measuring signal. The first and second transmitting loops have a property with a readable value dependent on an aging of the object of a wearable device. In addition, the data processing unit is configured to measure the value of the property of the first and second transmitting loops and determine the effects or amount of aging.

Systems and methods to determine and ensure proper usage technique of a respiratory medicament device for a respiratory ailment. Medication data relating to a medication plan for a patient is collected and used to determine the respiratory medicament device type in use. For respiratory medicament device types requiring multiple consecutive uses, use data is collected and used to determine proper or improper use technique based on the timing between consecutive uses of the respiratory medicament device. Notification of proper or improper usage technique are provided based on the determined usage technique. Real-time monitoring of the use data is used to provide directions on the required timing of consecutive uses of the respiratory medicament device and thus ensure proper usage technique.

The invention generally relates to systems and methods for providing detection, identification, and precision targeting of specific tissue(s) of interest in a nasal region of a patient for the treatment of a rhinosinusitis condition while minimizing or avoiding collateral damage to surrounding or adjacent non-targeted tissue, such as blood vessels, bone, and non-targeted neural tissue.